Cholestech liver test
This article was originally published in The Gray Sheet
Executive Summary
CLIA waiver for aspartate aminotransferase (AST) enzyme blood test is announced June 30. The diagnostic will be used with the firm's previously waived ALT enzyme test on the LDX System to monitor potential liver side effects from disease and cholesterol lowering drugs. Cholestech estimates nearly 200 mil. ALT and AST tests are ordered by clinicians annually in the U.S...